Berrin  Tuğrul

Ms. Berrin Tuğrul


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2011 in Medical Principles and Practice
Verified
Journal Article
Open access
PDF file
EOEce Onur
Ece Onur
AKAdnan Taner Kurdal
Adnan Taner Kurdal
BTBerrin Tuğrul
Berrin Tuğrul
IIIhsan Iskesen
Ihsan Iskesen
PDPınar Dundar
Pınar Dundar
AVAhmet Var
Ahmet Var
Objective: To determine the risk of an association with some genetic polymorphisms involved in venous thromboembolism (VTE) gene variations (FVL, FV H1299R, FII G20210A, MTHFR C677T, MTHFR A1298C, PAI-1 4G/5G, β-fibrinogen -455 G → A, FXIII Val34Leu and GpIIIa HPA-1a) in cancer patients. Subjects and Methods: Among 78 cancer patients, 28 who had proven first episode of VTE were selected as the patient group, with 50 control samples selected from age-, sex- and body mass index-matched healthy volunteers (healthy group). The differences in frequency of genetic polymorphisms were found to be statistically insignificant between these two groups. Results: Logistic regression analysis after adjustment for age, sex, smoking and hypertension showed no difference. The screened mutations of these genes were not significantly associated with VTE risk. Conclusion: There is no possible benefit from genetic screening tests regarding VTE in cancer patients.

18 January 2016 in African Health Sciences
Verified
Journal Article
Open access
PDF file
BTBerrin Tuğrul
Berrin Tuğrul
YHYılmaz Hikmet
Yılmaz Hikmet
VGVatandaş Gülşen
Vatandaş Gülşen
BFBozyiğit Ferda
Bozyiğit Ferda
BEBalcan Erdal
Balcan Erdal
OEOnur Ece
Onur Ece
Background: Idiopathic generalized epilepsy (IGE) is an epilepsy form without an underlying brain lesion or neurological indication or symptom. Recent investigations on the genetic origins of IGE and its subtypes report that certain mutations of various ion and non-ion channels genes in the central nervous system may be associated with IGE. Purpose: In this study we evaluated the relation between IGE and S430Y polymorphism in EFHC2 gene in a Turkish population. Material/methods: The study enrolled 96 healthy volunteers (47 male, 49 female), served as controls, and 96 IGE patients (41 male, 55 female), IGE diagnosis was confirmed in the neurology department. DNA extractions were performed. The presence of S430Y polymorphism in the exon 9 of EFHC2 gene were analyzed by Real-Time PCR. The findings obtained from the control and patient groups were compared. Results: In the patient group there was one heterozygous male with 685 T>C mutation. In the control group, there were two objects with 685 T>C mutation; one heterozygous male, one heterozygous female. 662 G>A mutation was determined in neither controls nor patients. Conclusion: In our series of 96 IGE patients and 96 healthy controls, there was no relation between S430Y polymorphism in EFHC2 gene and IGE presence. Keywords: EFHC2 gene polymorphism, idiopathic generalized epilepsy.

7 June 2016 in Cumhuriyet Medical Journal
Verified
Journal Article
Open access
PDF file
LOLatife Merve Oktay
Latife Merve Oktay
BTBerrin Tuğrul
Berrin Tuğrul
SUMMARY Objective: It has been shown that hydroxytryrosol (HT) has antitumoral, anti-proliferative and apoptotic effects on various cancer cell line types. In this study, we investigated cytotoxic and apoptotic effects of HTon human ovarian cancer cell lines OVCAR-3 and MDAH-2774 and relationship of its cytotoxic effects with phosphatidylinositol 3-kinase/Akt (PI3K/Akt) and extracellular signal-regulated kinase 1/2 (ERK 1/2) signaling pathways. Method: XTT cell proliferation kit, Cell Death Detection Elisa Plus Kit and Human Apoptosis Array test were used to determine the cytotoxic and apoptotic effects of HT in OVCAR-3 and MDAH-2774 cell lines at 24, 48, 72 and 96 hours (h). Effect of HT on PI3K/Akt and ERK 1/2 signaling pathways were investigated by using specific inhibitors of these pathways. Results: IC50 values of HT were found to be 102.3 μM in MDAH-2774 cells at 72 h and 51.5 μM in OVCAR-3 cells at 96 h. Highest apoptotic effect was seen at 100 μM concentration in OVCAR-3 cells at 96 h and at 50 μM at 72 h in MDAH-2774. HT increased the levels of pro-apoptotic molecules including Bad, Bax, active caspase-3, Htra2/Omi and of proapoptotic death receptors TRAIL R1/DR4, TRAIL R2/DR5, FAS/TNFRSF6 and decreased Survivin levels in MDAH-2774 cells. In OVCAR-3 cells, HT decreased Bcl-2, pro-caspase 3 and CIAP-1, CIAP-2, XIAP, Livin, Survivin levels and increased cytochrome-c level. The cell vitality was increased in both of the cell lines as the result of the treatment with HT and FR180204. Conclusions: These results show that HT has potential cytotoxic and apoptotic effect on OVCAR-3 and MDAH-2774 cells. In both cell lines, the cytotoxic effect of HT could be ocur inhibiting through ERK 1/2 signaling pathway. Keywords: apoptosis; cell line; cytotoxicity; ERK 1/2 pathway; hydroxytyrosol; ovarian cancer   ÖZET Amaç: Hiroksitirozolün (HT) çeşitli kanser hücre hatları üzerindeki antitümoral, çoğalmayı inhibe etme ve apoptotik etkileri olduğu gösterilmiştir. Bu çalışmada, insan yumurtalık kanser hücre hatları OVCAR-3 ve MDAH-2774 üzerinde HT’nin sitotoksik ve apoptotik etkilerini ve onun sitotoksik etkisinin fosfotidil 3-kinaz/Akt (PI3K/Akt) ve hücre dışı sinyalle düzenlenen kinaz 1/2 (ERK 1/2) ile ilişkisini araştırdık. Yöntem:  HT’nin, 24, 48, 72 ve 96 saatlik OVCAR-3 ve MDAH-2774 hücre kültürleri üzerinde sitotoksik ve apoptotik etkilerini belirlemek için, XTT hücre canlılık testi, hücre ölümünü belirleyen ELISA plus ve insan apoptoz array testi kullanıldı. HT’nin sitotoksik etkisinin PI3K/Akt ve ERK 1/2 sinyal yolakları ile ilişkisi, yolakların spesifik inhibitörleri kullanılarak araştırıldı. Bulgular: HT’nin IC50 değeri MDAH-2774 hücrelerinde 72. saatte 102.3 μM, OVCAR-3 hücrelerinde 96. saatte 51.5 μM bulundu. En yüksek apoptotik etki OVCAR-3 için 96. saatte 100 μM ve MDAH-2774 için 72. saatte 50 μM’da görüldü. HT, MDAH-2774 hücrelerinde Bad, Bax, aktif kaspaz-3, Htra2/Omi’nin dahil olduğu pro-apoptotik moleküllerin seviyesini ve TRAIL R1/DR4, TRAIL R2/DR5, FAS/TNFRSF6 içeren pro-apoptotik ölüm reseptörlerinin seviyesini artırdı. OVCAR-3 hücrelerinde HT, Bcl-2, pro-caspase 3 and CIAP-1, CIAP-2, XIAP, Livin, Survivin seviyelerini azalttı ve sitokrom-c seviyesini arttırdı. Hücre canlılığı, HT ile FR180204 uygulamasının sonucunda her iki hücre hattında arttı. Sonuç: Bu sonuçlar HT’nin OVCAR-3 ve MDAH-2774 hücreleri üzerinde sitotoksik ve apoptotik etki potansiyeline sahip olduğunu göstermektedir. Her iki kültür hücrelerinde HT’nin sitotoksik etkisi ERK 1/2 sinyal yolağını inhibe ederek gerçekleşiyor olabilir. Anahtar sözcükler: apoptoz; ERK 1/2 yolağı; hidroksitirozol; hücre hattı; sitotoksisite; yumurtalık kanseri


24 December 2019 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
BTBerrin Tuğrul
Berrin Tuğrul
SSSevinç Söylev
Sevinç Söylev
PTPeyker Temiz
Peyker Temiz
GGGülsüm Gençoğlan
Gülsüm Gençoğlan
Background: Cutaneous squamous cell carcinoma (cSCC) is a malignant and invasive tumor which is originated from epidermis with a high incidence among non-melanoma skin cancers. The aim of this study was to determine whether vitamin D receptor (VDR), calcium-sensing receptor (CaSR) and beta catenin (β-catenin) proteins have an effect on cSCC. Materials and methods: VDR, CaSR and β-catenin proteins in tissue samples of cSCC and control group were analyzed by immunohistochemistry (IHC) and Western blotting (WB) method. IHC findings were statistically evaluated. Results: IHC staining density of VDR and β-catenin were higher in cSCC tissue samples than control. The difference between IHC staining density of VDR and β-catenin in the patient and the control groups were statistically significant (p = 0.021, p = 0.021, respectively), but not for CaSR (p = 0.237). While the VDR and β-catenin staining rates obtained by the IHC method could be supported by WB results, the WB bands for CaSR could not be shown. Conclusion: The findings suggest that VDR and β-catenin may have an effect on the disease. Further research is required to better understand the role of VDR and β-catenin together on cSCC.

28 December 2023 in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Closed access
DADelfin Alpsoy
Delfin Alpsoy
BTBerrin Tuğrul
Berrin Tuğrul
ZÖZübeyde Öztel
Zübeyde Öztel
EBErdal Balcan
Erdal Balcan
Natural product-derived phytochemicals are now accepted as promising agents in developing new strategies for cancer treatment and prevention. The root extracts of valerian (Valeriana officinalis L.), which is a supplement widely used for improving circadian rhythm-dependent sleep disorders and insomnia, might be a good candidate in that context. In the present study we hypothesized whether extract of valerian root induce programmed cell death machineries in a human breast cancer model, MCF-7 cells. To test the hypothesis, we treated MCF-7 cells with the extract at different concentrations for 24 h. Giemsa staining was used to evaluate the apoptotic morphology and apoptotic index, and monodancylcadaverine assay was used to determine vacuoles that are associated with autophagic flux. Our results indicated that extracts of the roots of valerian have apototic and autophagic effect on human breast cancer cell MCF-7 in a dose dependent manner. Moreover, the typical cobblestone morphology of the cells was disrupted after the extract treatments and the cells lost contact with each other. This morphological alteration was attributed to anoikis, is a programmed cell death type induced by loss of cell communication with extracellular matrix or neighboring cells. In conclusion, although this study has many methodological shortcomings, our findings suggest that Valeriana officinalis L. might be a potential anti-cancer agent for the treatment of breast cancer.